JUN 20, 2016 07:00 AM PDT

Blood test could use shapes to spot cancer

A new way to detect antibodies in blood opens the door to developing simple diagnostic tests for diseases for which no microbial cause is known, including autoimmune diseases and cancer.

The results are the first evidence that it is possible to develop blood tests for any infectious disease by screening random libraries of non-biological molecular shapes.

Image Credit: iStockPhoto

“This ‘needle-in-a-molecular haystack’ approach is a new way to develop diagnostic assays,” says senior author Donald S. Burke, dean of the Graduate School of Public Health at the University of Pittsburgh.

“The method does not rely on starting with known viral components. This is important because there are conditions for which there isn’t a known antigen, such as newly emerged epidemics, autoimmune diseases, or even responses to traumatic injury.”

When a person’s immune system is faced with an antigen or foreign invader, such as an infectious disease, or even an injury with tissue damage, it responds by producing antibodies. Like puzzle pieces, specific parts of the surface of these antibodies fit to the shape of the molecules on the invader or the damaged tissue.

As reported in the Journal of Immunological Methods, the new technique, which synthesizes random molecular shapes called “peptoids” hooked onto microscopic plastic beads, can produce millions of molecular shapes. The peptoids are not organic, but if they match to the corresponding shape on an antibody, that antibody will connect to them, allowing the scientist to pull out that bead and examine that peptoid and its corresponding antibody.

Using this technique, researchers chemically generated a huge library of random molecular shapes. Then, using blood from HIV-infected patients and from non-infected people, they screened a million of these random molecular shapes to find the ones that bound only to antibodies present in the blood of HIV-infected patients, but not the healthy controls.

No HIV proteins or structures were used to construct or select the peptoids, but the approach, nonetheless, successfully led to selection of the best molecular shapes to use in screening for HIV antibodies.

The team then resynthesized that HIV-antibody-targeting peptoid in mass and tested it by screening hundreds of samples from the Multicenter AIDS Cohort Study (MACS), a confidential research study of the natural history of treated and untreated HIV/AIDS in men who have sex with men (supported by the National Institutes of Health).

Study coauthor Charles Rinaldo, chair of the infectious diseases and microbiology department selected the samples, but blinded the testers to which samples were HIV-positive or -negative. The test distinguished between the samples of HIV-positive blood and HIV-negative blood with a high degree of accuracy.

“This technology means that we may be able to take a single drop of blood from a patient and detect antibodies to all manner of infections, cancers, or other conditions they may be carrying or been exposed to,” Burke says.

“We hope that this is the first step toward development of an ‘Epi-chip’ that can be used to reconstruct a person’s entire exposure history.”

Other researchers from University of Pittsburgh and from the University of California, San Francisco, are coauthors of the study that was funded by the Bill & Melinda Gates Foundation.

Source: University of Pittsburgh

This article was originally posted on futurity.org.
About the Author
  • Futurity features the latest discoveries by scientists at top research universities in the US, UK, Canada, Europe, Asia, and Australia. The nonprofit site, which launched in 2009, is supported solely by its university partners (listed below) in an effort to share research news directly with the public.
You May Also Like
MAY 31, 2018
Technology
MAY 31, 2018
PUREGRIP: Safe, User-Friendly Bottles for Biomedical Research
Foxx Life Sciences and Borosil Glass Works Joined up to Create a Lab Bottle Breakthrough...
JUN 20, 2018
Genetics & Genomics
JUN 20, 2018
The Cause of a Rare Neurological Disease is Identified
In a recent study, scientists sequenced the genome to find the mutation behind a disorder that causes blindness and paralysis....
AUG 26, 2018
Genetics & Genomics
AUG 26, 2018
Why the Same Genetic Mutation can Affect People Differently
Scientists have been confounded for years by genetic errors with the sequence, but a different effect on people....
OCT 29, 2018
Immunology
OCT 29, 2018
Escape of the Tumor Cell
Tumor cells in breast cancer have proven to evade the immune responses utilizing actin cytoskeleton...
OCT 29, 2018
Immunology
OCT 29, 2018
Immunity for All
A study published in Nature has shed light on the evolution of immune system genes across species with great detail at the single-cell level...
NOV 21, 2018
Cardiology
NOV 21, 2018
What We Know About Kawasaki Disease
Kawasaki disease discovered by Dr. Tomisaku Kawasaki, a Japanese pediatrician, is a rare type of vasculitis, or inflammation of the blood vessels. It&rsquo...
Loading Comments...